Industry: Pharmaceuticals

According to a new EY report 'e-pharma: delivering healthier outcomes', e-pharma players are expected to attain a combined market size of US$2.7 billion by 2023 from about US$360 million currently in the next four years. The key growth driv
June 2, 2019, midnight

The industry has initiated attempts to make formulations exports with an aim to replace those going from the US.
May 29, 2019, 12:02 p.m.

The Centre for Cellular and Molecular Biology, and the Indian Pharmacopeia Commission, have joined hands to facilitate the regulatory process for biosimilars and herbal drugs.
April 29, 2019, 5:02 a.m.

China represents the second-largest drug market in the world with US$122bn in drug sales in 2017, and is growing in high single digits.
April 24, 2019, 12:11 p.m.

The domestic formulations business (secondary data) has witnessed 9.9% growth YoY during the January - March 2019 quarter.
April 17, 2019, 12:32 p.m.

Indian pharmaceutical market’s (IPM) secondary sales growth moderated to 8.9% YoY in Mar’19 versus 10% YoY in the previous month. Growth was driven by prices (+4.9% YoY), volumes (+1.5% YoY) and new launches (+2.4% YoY).
April 16, 2019, 12:29 p.m.

The pharmaceutical sector is in a recovery mode and the positive trajectory in earnings growth witnessed in 3QFY19 should also be visible in 4QFY19. Pricing pressure in the US has moderated and new products launched are contributing to growth.
April 5, 2019, 11:52 a.m.

Welchol generic – DRL has gained 9% market share for the product as against a low single-digit share at the end of the previous quarter. Glenmark Pharmaceuticals has also been able to expand its market share to 16% from 10% (at the end of the previous quarter).
March 28, 2019, 11:27 a.m.

MNC pharma companies are crying foul over the illegal import of drugs worth crores of rupees into the Indian market from neighbouring countries and sold by pharmacies, distributors and websites.
March 22, 2019, 5:49 a.m.

Aditya Khemka, fund Manager at DSP Investment Managers, breaks down the pharma sector from a portfolio perspective. Khemka, who was previously with Glenmark .
Feb. 12, 2019, midnight